Meeting
2019 Genitourinary Cancers Symposium
Targeting mediator subunits CDK8/CDK19 for treatment of advanced prostate cancer.
Authors
Marie C. Hupe
Department of Urology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
Marie C. Hupe , Anne Offermann , Finn Becker , Vincent Joerg , Wenzel Vogel , Johannes Braegelmann , Sven Perner , Axel Stuart Merseburger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 152)
DOI
10.1200/JCO.2019.37.7_suppl.152
Abstract #
152
Poster Bd #
F17
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Can free PSA be used as a biomarker in biochemical recurrence after surgery to predict castrate resistant prostate cancer?
First Author: Hanan Goldberg
Poster
2013 Genitourinary Cancers Symposium
A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort.
First Author: Matthew R. Cooperberg
Poster
2024 ASCO Genitourinary Cancers Symposium
ERBB3 expression in racially diverse patients with castration-sensitive prostate cancer and its association with a unique AR activity signature.
First Author: Jordan Vellky
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluation of a novel transcriptomic tumor signature (PROSTest) as response biomarker for 177Lu-PSMA therapy in advanced prostate cancer.
First Author: Alin Chirindel